Cancer diagnostics and therapeutics represent critical fronts in cancer research, aiming to improve detection and treatment outcomes. Diagnostic advancements, ranging from imaging techniques to liquid biopsies, enable earlier detection, leading to more effective intervention strategies. Molecular profiling and genetic testing further personalize treatment approaches, allowing clinicians to target specific mutations driving cancer growth. Therapeutic innovations include targeted therapies, immunotherapies, and precision medicine, which exploit tumor vulnerabilities while minimizing adverse effects on healthy tissues. Emerging modalities like CAR-T cell therapy hold promise for combating hematologic malignancies. Additionally, advancements in nanotechnology offer new avenues for drug delivery, enhancing treatment efficacy and reducing systemic toxicity. As research continues to unravel the complexities of cancer biology, the synergy between diagnostics and therapeutics stands poised to revolutionize cancer care, offering hope for improved outcomes and enhanced quality of life for patients.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States